Effects of D3 supplementation on ovulation in polycyctic ovarian syndrome (PCOS) patients

Authors

  • Reyadh H. Al-Mosawi M.B.Ch.B, M.Sc, P.hD in pharmacology and toxicology. Lecturer in Babylon University, College of Medicine Author
  • Nuha J. Hamood M.B.Ch.B, D.O.G, C.A.B.O.G. Karbla / Al-Hindiya General Hospital Author

DOI:

https://doi.org/10.61841/53hx5v98

Keywords:

D3 supplementation, ovulation, polycyctic ovarian syndrome (PCOS)

Abstract

Objectives: To explore the relation between vitamin D3 and ovulation in PCOS patients with vitamin D3 deficiency. Patients and Methods: 66 Patients were recruited from a private clinic in Karbala city / Al-Hindiya district. Criteria for selecting patients: aged 20-37 years, history of infertility, PCOS with low D3 blood level (<10ng/ml). The patients were divided into two groups (33 patients each), the first group treated with metformin 850mg, b.i.d, and placebo. The second group treated with metformin 850mg, b.i.d and vitamin D3 oral supplementation 5000 IU/day for 3 months. Ultrasonography was performed monthly on day 13 to assess the follicular size. D3 blood level was measured at the end of the 3 months. Data underwent one-way ANOVA testing and Dunnett's test for multiple comparisons.

Conclusion: The important finding was that D3 might affect follicular maturation in PCOS patients.

Downloads

Download data is not yet available.

References

1. Patra SK, Nasrat H, Goswami B, Jain A. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr. 2012;6:146–149.

2. Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism. 2011;60:1475–1481.

3. Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012;32:195–201.

4. Firouzabadi R, Aflatoonian A, Modarresi S, Sekhavat L, MohammadTaheri S. Therapeutic effects of calcium and vitamin D supplementation in women with PCOS. Complement Ther Clin Pract. 2012;18:85–88.

5. Pramyothin P, Biancuzzo RM, Lu Z, Hess DT, Apovian CM, Holick MF. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after Roux-en-Y gastric bypass. Obesity (Silver Spring). 2011;19:2228–2234.

6. Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxyvitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care. 2010;33:1373–1375.

7. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813–2818.

8. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: The Tromsø Study. Eur J Endocrinol. 2010;162:935–942.

9. Tao MF, Zhang Z, Ke YH, et al. Association of serum 25-hydroxyvitamin D with insulin resistance and beta-cell function in a healthy Chinese female population. Acta Pharmacol Sin. 2013;34:1070–1074.

10. Bellia A, Garcovich C, D’Adamo M, et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severely obese subjects. Intern Emerg Med. 2013;8:33–40.

11. Kim JJ, Choi YM, Chae SJ, et al. Vitamin D deficiency in women with polycystic ovary syndrome. Clin Exp Reprod Med. 2014;41:80–85.

12. Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77:343–350.

13. Naqvi SH, Moore A, Bevilacqua K, et al. Predictors of depression in women with polycystic ovary syndrome. Arch Womens Ment Health. 2014;18:95–101.

14. Raja-Khan N, Shah J, Stetter CM, et al. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: A randomized controlled pilot trial. Fertil Steril. 2014;101:1740–1746.

15. Gallea M, Granzotto M, Azzolini S, et al. Insulin and body weight but not hyperandrogenism seem involved in seasonal serum 25-OH-vitamin D3 levels in subjects affected by PCOS. Gynecol Endocrinol. 2014;30:739–745.

16. Yildizhan R, Kurdoglu M, Adali E, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009;280:559–563.

17. Irani M, Minkoff H, Seifer DB, Merhi Z. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab. 2014;99:E886–E890.

18. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: A systematic review. Eur J Endocrinol. 2012;166:765–778.

19. Anagnostis P, Karras S, Goulis DG. Vitamin D in human reproduction: A narrative review. Int J Clin Pract. 2013;67:225–235.

20. Wojtusik J, Johnson PA. Vitamin D regulates anti-Müllerian hormone expression in granulosa cells of the hen. Biol Reprod. 2012;86:91.

21. Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B. Vitamin D–associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol. 2011;164:741–749.

22. Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 production in human ovarian cells. Horm Metab Res. 2010;42:754–757.

23. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril. 2009;92:1053–1058.

24. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids. 1999;64:430–435.

25. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000;141:1317–1324.

26. Tilly JL. The molecular basis of ovarian cell death during germ cell attrition, follicular atresia, and luteolysis. Front Biosci. 1996;1:d1–11.

27. Behmanesh N, Abedelahi A, Alihemmati A. Effects of vitamin D supplementation on follicular development, gonadotropins, sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome. Turk J Obstet Gynecol. 2019;16(3):143–150.

Downloads

Published

01.06.2020

Issue

Vol. 24 No. 10 (2020): 24 (10) 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Al-Mosawi, R. H., & Hamood, N. J. (2020). Effects of D3 supplementation on ovulation in polycyctic ovarian syndrome (PCOS) patients. International Journal of Psychosocial Rehabilitation, 24(10), 2447-2455. https://doi.org/10.61841/53hx5v98